The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors

International Journal of Radiation Oncology Biology Physics

Volumn 42, Issue 4, 1998, Pages 895-898

  Horsman, Michael R ^a   Ehrnrooth, Eva ^b   Ladekarl, Morten ^b   Overgaard, Jens ^a  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

C3H mouse mammary carcinoma; Combretastatin A 4 disodium phosphate; Eppendorf histograph; Spontaneous murine tumors; Tumor hypoxia; Tumor necrosis

Indexed keywords

COMBRETASTATIN A4;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BREAST CARCINOMA; CONFERENCE PAPER; DRUG EFFECT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR NECROSIS; TUMOR REGRESSION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL HYPOXIA; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; NECROSIS; NEOPLASMS; OXYGEN CONSUMPTION; PARTIAL PRESSURE; STILBENES;

EID: 0031770618     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00299-5     Document Type: Conference Paper

References (14)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 82:1990;4-6.
2. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors a review . Cancer Res. 49:1989;6449-6465.
3. Denekamp J. Inadequate vasculature in solid tumours consequences for cancer research strategies . Br J Radiol. 24:(Suppl.):1992;111-117.
4. Denekamp J., Hill S. Angiogenic attack as a therapeutic strategy for cancer. Radiother Oncol. 20:(Suppl.):1991;103-112.
5. Horsman M.R. Modifiers of tumor blood supply. Urano M., Douple E. Hyperthermia and oncology. Vol. 4: Chemopotentiation by hyperthermia. 1994;259-283 VSP, Utrecht.
6. Chaplin D.J., Pettit G.R., Parkins C.S., Hill S.A. Antivascular approaches to solid tumour therapy evaluation of tubulin binding agents . Br J Cancer. 74:1996;S86-S88.
7. Dark G.G., Hill S.A., Prise V.E., Tozer G.M., Pettit G.R., Chaplin D.J. Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature. Cancer Res. 57:1997;1829-1834.
8. Vaupel P., Kallinowski F. Physiological effects of hyperthermia. Streffer C. Recent results in cancer research, Vol. 104: Hyperthermia and the therapy of malignant tumours. 1987;71-109 Springer-Verlag, Berlin.
9. Horsman M.R., Nordsmark M., Høyer M., Overgaard J. Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours. Br J Cancer. 72:1995;1474-1478.
10. Overgaard J. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo. Int J Radiat Oncol Biol Phys. 6:1980;1507-1517.
11. 2-histography. Int J Radiat Oncol Biol Phys. 19:1990;953-961.
12. Baguley B.C., Holdaway K.M., Thomsen L.I., Zhuang L., Zwi L.J. Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine evidence for a vascular mechanism . Eur J Cancer. 27:1991;482-487.
13. Hill S.A., Lonergan S.J., Denekamp J., Chaplin D.J. Vinca alkaloids anti-vascular effects in a murine tumour . Eur J Cancer. 29A:1993;1320-1324.
14. Horsman M.R., Sampson L.E., Chaplin D.J., Overgaard J. The in vivo interaction between flavone acetic acid and hyperthermia. Int J Hyperthermia. 12:1996;779-789.